[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mina  Pastagia M.D., MS", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": 537600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 66, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Rychlik", "age": 67, "title": "VP, Corporate Controller & Principal Financial Officer", "yearBorn": 1956, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "title": "Senior Vice President of Business & Corporate Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.5, "open": 2.6, "dayLow": 2.5, "dayHigh": 2.75, "regularMarketPreviousClose": 2.5, "regularMarketOpen": 2.6, "regularMarketDayLow": 2.5, "regularMarketDayHigh": 2.75, "beta": 0.701, "forwardPE": -1.9615386, "volume": 31040, "regularMarketVolume": 31040, "averageVolume": 16285, "averageVolume10days": 11350, "averageDailyVolume10Day": 11350, "bidSize": 1200, "askSize": 1200, "marketCap": 92173832, "fiftyTwoWeekLow": 1.07, "fiftyTwoWeekHigh": 5.26, "priceToSalesTrailing12Months": 20.351917, "fiftyDayAverage": 3.5218, "twoHundredDayAverage": 2.9238, "currency": "USD", "enterpriseValue": 199026768, "floatShares": 10716234, "sharesOutstanding": 36146600, "sharesShort": 14148, "sharesShortPriorMonth": 29623, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.70346, "heldPercentInstitutions": 0.03592, "shortRatio": 0.73, "shortPercentOfFloat": 0.0011999999, "impliedSharesOutstanding": 36485400, "bookValue": -0.888, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -69045000, "trailingEps": -1.91, "forwardEps": -1.3, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 43.945, "enterpriseToEbitda": -4.986, "52WeekChange": 0.5361446, "SandP52WeekChange": 0.21231294, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "ARMP", "underlyingSymbol": "ARMP", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 769440600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e9006f47-0d3e-3b07-8861-14c121fcb2a4", "messageBoardId": "finmb_84546611", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.55, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "totalCash": 13523000, "totalCashPerShare": 0.374, "ebitda": -39918000, "totalDebt": 120371000, "quickRatio": 1.026, "currentRatio": 1.163, "totalRevenue": 4529000, "revenuePerShare": 0.126, "returnOnAssets": -0.26319999, "returnOnEquity": -34.39352, "freeCashflow": -27746500, "operatingCashflow": -47423000, "revenueGrowth": 0.454, "operatingMargins": -6.26898, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]